Organization · Venture Capital
Karolinska Institutet Holding
Karolinska Institutet Holding AB is a Swedish holding company that manages the commercialization of innovations in life sciences and medical technology, bridging academic research to market-ready companies.
Overview
What Karolinska Institutet Holding does
What Karolinska Institutet Holding is
Karolinska Institutet Holding AB is a Swedish holding company that manages the commercialization of innovations in life sciences and medical technology, bridging academic research to market-ready companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1995
- Approximate age
- About 31 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Karolinska Institutet Holding elsewhere
Open the official website or a supported primary organization account.
Capability profile
Karolinska Institutet Holding as a funder
Investment thesis
Karolinska Institutet Holding focuses on the professional evaluation, development, and commercialization of innovations in Life Science and Medical Technology, bridging academic research to market-ready companies.
Focus narrative
Karolinska Institutet Holding invests in and provides services related to Life Science and Medical Technology. The organization develops research ideas from both Swedish and other Nordic universities, facilitating the transition from early ideas to commercial products.
Value beyond capital
Karolinska Institutet Holding adds value by providing early-stage support, including coaching, expert networks, and direct seed investments in spinouts, thereby facilitating the commercialization of research-based innovations.
Portfolio and track record
- Recorded portfolio count
- 5
- Recorded notable exits
- Karolinska Development AB
Portfolio context
Notable portfolio companies include Ciprocity, which develops software for confocal microscopy; AAX BioTech, focusing on antibody improvement technologies; Volumeer AB, specializing in sepsis diagnostics; SEQURNA, which offers RNA preservation reagents; and Clinsight, working on prostate cancer diagnostics standardization.
Common questions
What to know about Karolinska Institutet Holding
Upseed classifies Karolinska Institutet Holding under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.